Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7411 USD | +2.42% | +6.25% | -74.71% |
May. 13 | Spruce Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 15 | North American Morning Briefing : Inflation -2- | DJ |
Financials (USD)
Sales 2024 * | 6.65M | Sales 2025 * | 1.67M | Capitalization | 30.5M |
---|---|---|---|---|---|
Net income 2024 * | -50M | Net income 2025 * | -56M | EV / Sales 2024 * | -2.05 x |
Net cash position 2024 * | 44.1M | Net cash position 2025 * | 89.5M | EV / Sales 2025 * | -35.3 x |
P/E ratio 2024 * |
-0.6
x | P/E ratio 2025 * |
-0.74
x | Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.25% |
Latest transcript on Spruce Biosciences, Inc.
1 day | +2.42% | ||
1 week | +6.25% | ||
1 month | -0.07% | ||
3 months | -85.94% | ||
6 months | -50.26% | ||
Current year | -74.71% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 22-01-02 | |
Samir Gharib
DFI | Director of Finance/CFO | 41 | 20-04-30 |
Michael Grey
CHM | Chairman | 71 | 17-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Spiegelman
BRD | Director/Board Member | 65 | 20-09-08 |
Michael Grey
CHM | Chairman | 71 | 17-03-31 |
Tiba Aynechi
BRD | Director/Board Member | 48 | 16-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.7411 | +2.42% | 350,406 |
24-05-30 | 0.7236 | +3.30% | 284,818 |
24-05-29 | 0.7005 | +3.38% | 338,994 |
24-05-28 | 0.6776 | -2.85% | 520,757 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-74.71% | 30.5M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- SPRB Stock